| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $559,918 ) |
| | 2026 | 2026 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01CA279220 | SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT) | 000 | 3 | NIH | 2/26/2026 | $144,806 |
| | 2026 | 2026 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01DK134502 | Effects of Cholesterol in Pancreatic Islets | 000 | 4 | NIH | 3/23/2026 | $430,797 |
| | 2026 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01HL179905 | Optimizing Medications and Lung Health in People with HIV through Pharmacist-led Proactive E-Consults (OPTIMIZE Lung-HIV) | 000 | 1 | NIH | 11/27/2025 | $0 |
| | 2026 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01HL179905 | Optimizing Medications and Lung Health in People with HIV through Pharmacist-led Proactive E-Consults (OPTIMIZE Lung-HIV) | 000 | 1 | NIH | 11/27/2025 | $0 |
| | 2026 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01DK133317 | Role of the Renin-Angiotensin System in Glucose Homeostasis | 000 | 4 | NIH | 3/2/2026 | $0 |
| | 2026 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01DK132355 | Circulating miRNAs and prediction of beta-cell treatment response: The Restoring Insulin Secretion Study | 000 | 4 | NIH | 11/3/2025 | $0 |
| | 2026 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01CA239208 | Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer | 000 | 6 | NIH | 2/20/2026 | $0 |
| | 2026 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01CA243907 | Improving the Reach and Effectiveness of Smoking Cessation Services Targeted to Veterans Living with HIV | 001 | 6 | NIH | 3/3/2026 | $0 |
| | 2026 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01CA243907 | Improving the Reach and Effectiveness of Smoking Cessation Services Targeted to Veterans Living with HIV | 000 | 6 | NIH | 1/29/2026 | $0 |
| | 2026 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01AG075338 | Role of Astrocyte EAAT2/GLT1 Failure in Alzheimer's Disease Pathogenesis | 004 | 4 | NIH | 3/25/2026 | $0 |
| | 2026 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01AG075338 | Role of Astrocyte EAAT2/GLT1 Failure in Alzheimer's Disease Pathogenesis | 000 | 4 | NIH | 2/18/2026 | $0 |
| | 2026 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01AG061558 | Improving cancer-related fatigue, sexual dysfunction and quality of life in older men with cancer and androgen deficiency | 000 | 5 | NIH | 3/12/2026 | $0 |
| | 2026 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | U01NS100610 | Dementia with Lewy Bodies Consortium | 001 | 9 | NIH | 3/17/2026 | $0 |
| | 2026 | 2024 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R61AG080614 | Tai Chi Practice and Sleep-Active Glymphatic Function | 000 | 2 | NIH | 12/16/2025 | $0 |
| | 2026 | 2023 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01AR078487 | Helping patients and physicians choose the appropriate surgery for end stage hallux rigidus | 000 | 3 | NIH | 2/25/2026 | -$11,831 |
| | 2026 | 2022 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | RF1NS128966 | Defining the Role of Post-TBI Sleep Disruption in the Development of CTE and Alzheimer's Disease-Related Neuropathology | 000 | 1 | NIH | 3/23/2026 | $0 |
| | 2026 | 2021 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | U01HL142103 | AdvanCing High quality COPD care for people with immune dysfunction by implementing Evidence-based management through proactive E-consults (ACHIEVE) | 000 | 4 | NIH | 12/4/2025 | -$3,854 |
|
| Issue Date FY: 2025 ( Subtotal = $10,873,681 ) (Continued on the next page) |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01AG061558 | Improving cancer-related fatigue, sexual dysfunction and quality of life in older men with cancer and androgen deficiency | 001 | 5 | NIH | 4/15/2025 | $0 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01NS128966 | Defining the Role of Post-TBI Sleep Disruption in the Development of CTE and Alzheimer's Disease-Related Neuropathology | 000 | 2 | NIH | 8/20/2025 | $1,253,356 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R21MH137701 | GRABbing Serotonin During Fear | 000 | 1 | NIH | 9/24/2025 | $359,433 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01HL179905 | Optimizing Medications and Lung Health in People with HIV through Pharmacist-led Proactive E-Consults (OPTIMIZE Lung-HIV) | 000 | 1 | NIH | 8/13/2025 | $778,801 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01HL179905 | Optimizing Medications and Lung Health in People with HIV through Pharmacist-led Proactive E-Consults (OPTIMIZE Lung-HIV) | 000 | 1 | NIH | 8/13/2025 | $25,000 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01HL179905 | Optimizing Medications and Lung Health in People with HIV through Pharmacist-led Proactive E-Consults (OPTIMIZE Lung-HIV) | 001 | 1 | NIH | 9/23/2025 | $0 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01HL179905 | Optimizing Medications and Lung Health in People with HIV through Pharmacist-led Proactive E-Consults (OPTIMIZE Lung-HIV) | 001 | 1 | NIH | 9/23/2025 | $0 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01CA243907 | Improving the Reach and Effectiveness of Smoking Cessation Services Targeted to Veterans Living with HIV | 001 | 6 | NIH | 5/21/2025 | $0 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01CA243907 | Improving the Reach and Effectiveness of Smoking Cessation Services Targeted to Veterans Living with HIV | 000 | 6 | NIH | 2/28/2025 | $305,838 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | U01NS100610 | Dementia with Lewy Bodies Consortium | 001 | 9 | NIH | 9/9/2025 | $1,215,498 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01AG084552 | Investigating how SUT-6/NIPP1 regulates pathological tau | 001 | 2 | NIH | 6/10/2025 | $41,086 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01AG084552 | Investigating how SUT-6/NIPP1 regulates pathological tau | 000 | 2 | NIH | 3/31/2025 | $462,220 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R00AG073455 | Mutant Tubulins Confer Resistance to Pathological Tau | 000 | 5 | NIH | 7/11/2025 | $244,021 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01DK134502 | Effects of Cholesterol in Pancreatic Islets | 000 | 3 | NIH | 4/10/2025 | $387,718 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01NS129573 | Role of Sleep Disruption after mTBI as a Driver of Chronic Post-traumatic Headache | 000 | 3 | NIH | 6/13/2025 | $600,438 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01DK132355 | Circulating miRNAs and prediction of beta-cell treatment response: The Restoring Insulin Secretion Study | 000 | 4 | NIH | 2/26/2025 | $461,835 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01DA052618 | Microglia and Opioid Withdrawal: Mechanisms of Negative Reinforcement | 000 | 5 | NIH | 6/17/2025 | $397,287 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01AG066729 | TDP-43 in Alzheimer's disease | 000 | 5 | NIH | 4/28/2025 | $460,291 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01AG066729 | TDP-43 in Alzheimer's disease | 001 | 5 | NIH | 6/13/2025 | $40,915 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01CA239208 | Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer | 000 | 6 | NIH | 4/30/2025 | $465,404 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01CA239208 | Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer | 001 | 6 | NIH | 5/22/2025 | $51,711 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01AG084680 | Formation of Tau RNA Complexes disrupts tau function and drives tau neuropathology | 000 | 3 | NIH | 7/10/2025 | $661,062 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01CA279220 | SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT) | 001 | 2 | NIH | 7/16/2025 | $64,880 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01CA279220 | SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT) | 000 | 2 | NIH | 1/13/2025 | $583,926 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01AG075338 | Role of Astrocyte EAAT2/GLT1 Failure in Alzheimer's Disease Pathogenesis | 001 | 4 | NIH | 8/11/2025 | $57,231 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01AG075338 | Role of Astrocyte EAAT2/GLT1 Failure in Alzheimer's Disease Pathogenesis | 000 | 4 | NIH | 1/15/2025 | $643,846 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01NS119897 | Investigating the role of lipid metabolism in protein aggregation and neurodegenerative disease progression | 001 | 5 | NIH | 9/2/2025 | $0 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01NS119897 | Investigating the role of lipid metabolism in protein aggregation and neurodegenerative disease progression | 000 | 5 | NIH | 11/26/2024 | $318,592 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01DK133317 | Role of the Renin-Angiotensin System in Glucose Homeostasis | 000 | 4 | NIH | 6/30/2025 | $392,118 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01AG061558 | Improving cancer-related fatigue, sexual dysfunction and quality of life in older men with cancer and androgen deficiency | 002 | 5 | NIH | 6/13/2025 | $54,036 |
| | 2025 | 2025 | SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH | 1660 S COLUMBIAN WAY | SEATTLE | WA | 98108-1532 | KING | USA | R01AG061558 | Improving cancer-related fatigue, sexual dysfunction and quality of life in older men with cancer and androgen deficiency | 000 | 5 | NIH | 3/27/2025 | $607,889 |
|
